RETATRUTIDE 10MG - GLP-3

Retatrutide 10mg – a novel multi-agonist peptide studied for its roles in This is a GLP-3. Retatrutide is an experimental triple hormone receptor agonist that targets: • GLP-1 • GIP (glucose-dependent insulinotropic polypeptide) • Glucagon receptors This makes it more than a traditional GLP-1 — it’s a multi-agonist acting on three pathways to potentially produce greater weight loss and metabolic effects than single-pathway drugs. The GLP-3 is the combination of GLP-1, GIP, and glucagon receptor pathways, with potential applications in metabolic and weight research.